© 2020 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
FDA weighs whether to resume coronavirus vaccine trial halted due to an adverse event.
A U.K. woman developed spinal inflammation after receiving an adenovirus vector vaccine.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
The World Health Organization coordinates efforts to create flu and COVID-19 vaccines and to fight other global health issues.
The trial will enroll healthy volunteers to test the vaccine’s safety and ability to trigger an immune response.
Sci-B-Vac may offer more protection for older people and those with a weaker immune system.
People who received the vaccine did, however, show stronger immune responses against the virus.
Join us to promote awareness and education about HPV infection and associated diseases like cervical cancer that HPV vaccination can prevent
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
